Browsing: biocon rating

Valuation of Viatris’ biz is expensive; FY23/24e EPS up 3.4/15% with TP at Rs 385; ‘Neutral’ retained given limited upside…

Despite strong sales growth, ebitda margins at 22.5% declined 177bps QoQ on higher raw material costs), higher other costs (e.g.…

We recently met with BIOS’ management to understand its business outlook in greater detail. Here are the key takeaways: After…